A Randomized, Double-blind, Active-controlled, Multicenter Phase3 Trial to Evaluate the Efficacy and Safety of Co-administrated Temisartan/Amlodipine and Rosuvastatin in Subjects With Hypertension and Hyperlipidemia

Trial Profile

A Randomized, Double-blind, Active-controlled, Multicenter Phase3 Trial to Evaluate the Efficacy and Safety of Co-administrated Temisartan/Amlodipine and Rosuvastatin in Subjects With Hypertension and Hyperlipidemia

Recruiting
Phase of Trial: Phase III

Latest Information Update: 29 Apr 2017

At a glance

  • Drugs Amlodipine/rosuvastatin/telmisartan (Primary) ; Amlodipine/telmisartan; Rosuvastatin
  • Indications Hyperlipidaemia; Hypertension
  • Focus Therapeutic Use
  • Sponsors Yuhan
  • Most Recent Events

    • 13 Apr 2017 Status changed from planning to recruiting.
    • 30 Nov 2016 New trial record
    • 31 Oct 2016 According to an Yuhan media release, this trial will start as early as in November.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top